Aldose reductase in the polyol pathway: A potential target for the therapeutic intervention of diabetic complications

Folia Pharmacologica Japonica

Volumn 111, Issue 3, 1998, Pages 137-145

  Nishimura Yabe, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aldo ketoreductase family risk factor; Aldose reductase; Diabetic complications; Polyol pathway

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; FRUCTOSE; GLUCOSE; IDITOL DEHYDROGENASE; POLYOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SORBITOL;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE PREDISPOSITION; GLUCOSE METABOLISM; IMMUNOASSAY; MOUSE; NONHUMAN; RISK FACTOR; TRANSGENIC ANIMAL;

EID: 0031940496     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.111.137     Document Type: Conference Paper

References (50)

1. Kinoshita JH and Nishimura C: The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 4, 323-337 (1988)
2. Brownlee M, Cerami A and Vlassara H: Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular diseases. Diabetes Metab Rev 4, 437-451 (1988)
3. Lee T-S, Saltsman KA, Ohashi H and King GL: Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86, 5141-5145 (1989)
4. Williams B: Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertens 13, 477-486 (1995)
5. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N and Yagi K: Lipid peroxide level in plasma of diabetic patients. Biochem Med 21, 104-107 (1979)
6. González RG, Barnett P, Aguayo J, Cheng HM and Chylack LTJ: Direct measurement of polyol pathway activity in the ocular lens. Diabetes 33, 196-199 (1984)
7. Yabe-Nishimura C: Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol Rev, in press.
8. Pugliese G, Tilton GT and Williamson JR: Glucose- induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 7, 35-59 (1991)
9. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94, 853-859 (1994)
10. Yagihashi S, Yamagishi S, Wada R, Sugimoto K, Baba M, Wong HG, Fujimoto J, Nishimura C and Kokai Y: Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes 45, 56-59 (1996)
11. Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J and Kokai Y: Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38, 255-261 (1995)
12. Jez JM, Flynn GF and Penning TM: A nomenclature system for the aldo-keto reductase superfamily. In Enzymology and Molecular Biology of Carbonyl Metabolism 6, Edited by Weiner H, Lindahl R, Crabb DW and Flynn TG, Vol 414, pp 579-589, Plenum Press, New York (1996)
13. Carper D, Nishimura C, Shinohara T, Dietzchold B, Wistow G, Craft C, Kador P and Kinoshita JH: Aldose reductase and p-crystallin belong to the same protein superfamily as aldehyde reductase. FEBS Lett 220, 209-213 (1987)
14. Schade SZ, Early SL, Williams TR, Kezdy FJ, Heinrikson RL, Grimshaw CE and Doughty CC: Sequence analysis of bovine lens aldose reductase. J Biol Chem 265, 3628-3635 (1990)
15. Garcia-Perez A, Martin B, Murphy HR, Uchida S, Murer H, Cowley BD Jr, Handler JS and Burg MB: Molecular cloning of cDNA coding for kidney aldose reductase. Regulation of specific mRNA accumulation by NaCl-mediated osmotic stress. J Biol Chem 264, 16815-16821 (1989)
16. Bohren KM, Bullock B, Wermuth B and Gabbay KH: The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 264, 9547-9551 (1989)
17. Nishimura C, Matsuura Y, Kokai Y, Akera T, Carper D, Morjana N, Lyons C and Flynn TG: Cloning and expression of human aldose reductase. J Biol Chem 265, 9788-9792 (1990)
18. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T and Tanimoto T: Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta 1078, 171-178 (1991)
19. Pailhoux EA, Martinez A, Veyssiere GM and Jean CG: Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily. J Biol Chem 265, 19932-19936 (1990)
20. Gui T, Tanimoto T, Kokai Y and Nishimura C: Presence of a closely related subgroup in the aldoketoreductase family of the mouse. Eur J Biochem 227, 448-453 (1995)
21. Donohue PJ, Alberts GF, Hampton BS and Winkles JA: A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J Biol Chem 269, 8604-8609 (1994)
22. Wilson DK, Nakano T, Petrash JM and Quiocho FA: 1.7 Å structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor. Biochemistry 34, 14323-14330 (1995)
23. Rondeau JM, Tete FF, Podjarny A, Reymann JM, Barth P, Biellmann JF and Moras D: Novel NADPH- binding domain revealed by the crystal structure of aldose reductase. Nature 355, 469-472 (1992)
24. Wilson DK, Bohren KM, Gabbay KH and Quiocho FA: An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 257, 81-84 (1992)
25. Wilson DK, Tarle I, Petrash JM and Quiocho FA: Refined 1.8 Å structure of human aldose reductase complexed with the potent inhibitor zopolrestat. Proc Natl Acad Sci USA 90, 9847-9851 (1993)
26. Urzhumtsev A, Téte-Favier F, Mitschler A, Barbanton J, Barth P, Urzhumtseva L, Biellmann J-F, Podjarny AD and Moras D: A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 5, 601-612 (1997)
27. Burg MB: Molecular basis of osmotic regulation. Am J Physiol 268, F983-996 (1995)
28. Nishimura C, Graham C, Hohman TC, Nagata M, Robison WG Jr and Carper D: Characterization of mRNA and genes for aldose reductase in rat. Biochem Biophys Res Commun 153, 1051-1059 (1988)
29. Wermuth B and Monder C: Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity. Eur J Biochem 131, 423-426 (1983)
30. Matsuura K, Deyashiki Y, Bunai Y, Ohya I and Hara A: Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands. Arch Biochem Biophys 328, 265-271 (1996)
31. Turner AJ and Tipton KF: The characterization of two reduced nicotinamide-adenine dinucleotide phosphate-linked aldehyde reductases from pig brain. Biochem J 130, 765-772 (1972)
32. Vander Jagt DL, Robinson B, Taylor KK and Hunsaker LA: Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 267, 4364-4369 (1992)
33. Kolb NS, Hunsaker LA and Vander Jagt DL: Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol Pharmacol 45, 797-801 (1994)
34. Iwata N, Hara S, Nishimura C, Takahashi M, Mukai T, Takayama M and Endo T: Hormonal regulation of aldose reductase in rat ovary during the estrous cycle. Eur J Biochem 235, 444-448 (1996)
35. Graham A, Brown L, Hedge PJ, Gammack AJ and Markham AF: Structure of the human aldose reductase gene. J Biol Chem 266, 6872-6877 (1991)
36. Brown L, Hedge PJ, Markham AF and Graham A: A human aldehyde dehydrogenase (aldose reductase) pseudogene: nucleotide sequence analysis and assignment to chromosome 3. Genomics 13, 465-468 (1992)
37. Bateman JB, Kojis T, Heinzmann C, Klisak I, Diep A, Carper D, Nishimura C, Mohandas T and Sparkes RS: Mapping of aldose reductase gene sequences to human chromosomes 1, 3, 7, 9, 11, and 13. Genomics 17, 560-565 (1993)
38. Wang K, Bohren KM and Gabbay KH: Characterization of the human aldose reductase gene promoter. J Biol Chem 268, 16052-16058 (1993)
39. Bagnasco SM, Uchida S, Balaban RS, Kador PF an Burg MB: Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc Natl Acad Sci USA 84, 1718-1720 (1987)
40. Kaneko M, Carper D, Nishimura C, Millen J, Bock M and Hohman TC: Induction of aldose reductase expression in rat kidney mesangial cells and Chinese hamster ovary cells under hypertonic conditions. Exp Cell Res 188, 135-140 (1990)
41. Henry DN, Del MM, Greene DA and Killen PD: Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest 92, 617-623 (1993)
42. Ko BCB, Ruepp B, Bohren KM and Gabbay KH: Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 272, 16431-16437 (1997)
43. Nishimura C, Lou MF and Kinoshita JH: Depletion of myo-inositol and amino acids in galactosemic neuropathy. J Neurochem 49, 290-295 (1987)
44. Vander Jagt DL, Hunsaker LA, Robinson B, Stangebye LA and Deck LM: Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms. J Biol Chem 265, 10912-10918 (1990)
45. Hamada Y, Kitoh R and Raskin P: Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 40, 1233-1240 (1991)
46. Nishimura C, Furue M, Ito T, Omori Y and Tanimoto T: Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase. Biochem Pharmacol 46, 21-28 (1993)
47. Nishimura C, Hamada Y, Tachikawa T, Ishikawa T, Gui T, Tsubouchi J, Hotta N, Tanimoto T and Urakami T: Enzyme immunoassay for erythrocyte aldose reductase. Clin Chem 40, 889-894 (1994)
48. Nishimura C, Saito T, Ito T, Omori Y and Tanimoto T: High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37, 328-330 (1994)
49. Nishimura C, Hotta Y, Gui T, Seko A, Fujimaki T, Ishikawa T, Hayakawa M, Kanai A and Saito T: The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy. Diabetes Res Clin Pract 37, 173-177 (1997)
50. Ito T, Nishimura C, Takahashi Y, Saito T and Omori Y: The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy? Diabetes Res Clin Pract 36, 161-167 (1997)